studyId: syn53604892 studyName: Advancing RAS pathway targeted therapy in NF1-MPNST - effects of SHP2 and CDK4 or CDK6 inhibitors on the tumor and the tumor immune microenvironment initiative: Other fundingAgency: Other
Drop files to upload
ST8814_TNORes_TNO_2_trimmed_1.fastq.gz_trimming_report.txt page is loading…